Momentum Stocks: Anadigics (NASDAQ:ANAD), Anacor Pharmaceuticals (NASDAQ:ANAC), Ambarella (NASDAQ:AMBA), Haemonetics Corporation (NYSE:HAE), Demand Media (NYSE:DMD)

On Monday shares of Anadigics, Inc. (NASDAQ:ANAD) closed at $1.30. Company’s sales growth for last 5 years was -9.30% and EPS growth for next 5 years is recorded as 20.00%. ANADIGICS, Inc. (NASDAQ:ANAD) announced that it will release its first quarter results on May 5, 2015 at approximately 4:00 pm Eastern Time.

Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) in last trading activity advanced 3.57% to close at $56.34. Company weekly performance is -3.77% while its quarterly performance stands at 49.28%. Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) is -18.23% away from its 52 week high. Jefferies analyst David Steinberg reiterated a Buy rating and boosted his price target on Anacor Pharmaceuticals (NASDAQ:ANAC) to $70.00 (from $57.00) after raising AN2728 estimates given higher pricing assumptions.

On last trading day Ambarella, Inc. (NASDAQ:AMBA) moved down -0.85% to close at $75.40. Its volatility for the week is 4.25% while volatility for the month is 3.21%. AMBA’s sales growth for past 5 years was 25.00% and its EPS growth for past 5 years was 26.20%. Ambarella, Inc. (NASDAQ:AMBA) monthly performance is 1.89%.

Haemonetics Corporation (NYSE:HAE) has 0.60% insider ownership. In last trading activity company’s stock closed at $40.83. Haemonetics Corporation (NYSE:HAE) swung to a net loss for the quarter ended Mar. 28, 2015. The company has made a net loss of $2.93 million, or $ 0.06 a share in the quarter, against a net profit of $10.18 million, or $0.19 a share in the last year period.

On last trading day Demand Media, Inc. (NYSE:DMD) advanced 0.93% to close at $6.50. Its volatility for the week is 4.74% while volatility for the month is 4.79%. DMD’s sales growth for past 5 years was -2.80% and its EPS growth for past 5 years was 10.60%. Demand Media, Inc. (NYSE:DMD) monthly performance is 15.45%. On April 30, Demand Media, Inc. (NYSE:DMD), announced that respected financial leader Rachel Glaser has joined its executive team as Chief Financial Officer and that seasoned business executive Tawn Albright has been named Executive Vice President, Corporate Development.

Leave a Reply

Your email address will not be published. Required fields are marked *

*